The 20 Best Fibrolamellar Carcinoma Doctors Near Me

Dr. Mark Yarchoan is a physician–scientist based in Baltimore who specializes in the treatment and study of gastrointestinal cancers, with a particular focus on liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). He received his undergraduate degree from Amherst College and his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed his residency in internal medicine at the Hospital of the University of Pennsylvania, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine, where he joined the faculty in 2018. Dr. Yarchoan leads a research laboratory dedicated to developing novel immunotherapies for liver cancers. His translational research program integrates analyses of clinical trial biospecimens with preclinical modeling to identify and overcome barriers to effective antitumor immunity. A major focus of his work is the development of therapeutic cancer vaccines for hepatobiliary malignancies. He serves as Principal Investigator on multiple clinical trials for hepatobiliary cancers, contributes to international guideline committees for liver cancer, and is a member of the Johns Hopkins Graduate Training Programs in Cellular and Molecular Medicine and Immunology. Dr. Yarchoan’s contributions have been recognized with numerous honors, including the ASCO Young Investigator Award, the Conquer Cancer Foundation Career Development Award, the Mark R. Clements Award from the Cholangiocarcinoma Foundation, and the Blue Faery Award for Excellence in Liver Cancer Research. Dr. Yarchoan is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Pancreatic Cancer, and Hepatectomy. Dr. Yarchoan is board certified in American Board Of Internal Medicine.

Marina Baretti, MD, is an assistant professor at Johns Hopkins University School of Medicine and the Jiasheng Chair in Hepato-Biliary Cancer Research. She also serves as Co-Director of the Liver and Biliary Cancer Multidisciplinary Clinic at the Sidney Kimmel Comprehensive Cancer Center (SKCCC). Dr. Baretti received her medical degree from the University of Pisa in Italy. She completed her internal medicine residency and oncology fellowship at University of Milan. She then went on and completed her Postdoctoral and Medical Oncology Fellowship at Johns Hopkins University, Baltimore, Maryland. She is deeply engaged in bridging the gap between laboratory discoveries and clinical application, working closely with laboratory-based scientists to accelerate the development of novel therapeutic strategies. Her academic research is centered on the development of novel agents in hepatobiliary cancers, with particular interest in combinatorial approaches of immunotherapies. She is currently the principal investigator on multiple clinical trials in FLC, HCC and cholangiocarcinoma at Johns Hopkins University, collaborating closely with laboratory-based researchers to move laboratory findings into patients. Through her work, Dr. Baretti strives to improve outcomes for patients with rare GI cancers by identifying innovative therapies that are informed by a deeper understanding of tumor biology and the tumor microenvironment. Dr. Baretti was the recipient of the 2018 American Society of Clinical Oncology Young Investigator Award. Dr. Baretti was also awarded with the 2020 Career Development Award for the MD Anderson Cancer Center’s pancreatic cancer NCI Specialized Programs of Research Excellence (SPORE). Dr. Baretti is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, and Pancreatic Cancer.

Joseph Lee is a General Surgeon practicing medicine in Johnson City, Tennessee. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Lee is board certified in American Board Of Surgery.

Gregory Nadolski is a Radiologist practicing medicine in Philadelphia, Pennsylvania. Dr. Nadolski is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Chylous Ascites, Kimura Disease, Fibrolamellar Carcinoma, Liver Embolization, and Gastrostomy. Dr. Nadolski is board certified in American Board Of Radiology.

Dr. John Gordan is a gastrointestinal cancer specialist who cares for patients with hepatobiliary cancers, such as cholangiocarcinoma (bile duct cancer), hepatocellular carcinoma (the most common liver cancer) and gallbladder cancer. Gordan is actively involved in designing and carrying out clinical trials of potential treatments for hepatocellular carcinoma and cholangiocarcinoma. His laboratory research focuses on identifying new therapies for patients with these cancers as well as identifying predictive biomarkers to better apply existing therapies. Gordan completed his medical degree at the University of Pennsylvania, followed by a residency in internal medicine and a fellowship in medical oncology at UCSF. He joined the UCSF faculty in 2015. Gordan is a member of the American Society of Clinical Oncology, which supports his research, as does the American Cancer Society. Dr. Gordan is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Gallbladder Adenocarcinoma, and Tissue Biopsy. Dr. Gordan is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Gordan is currently accepting new patients.

Kanishka Chakraborty is a Hematologist and an Oncologist practicing medicine in Kingsport, Tennessee. Dr. Chakraborty is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Angiosarcoma, and Bone Marrow Aspiration. Dr. Chakraborty is board certified in American Board Of Internal Medicine.

Eyob Feyssa is an Internal Medicine provider practicing medicine in West Reading, Pennsylvania. Dr. Feyssa is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis C, Visceromegaly, Liver Transplant, and Endoscopy. Dr. Feyssa is board certified in American Board Of Internal Medicine.

Dr. Landis is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. He truly enjoys the challenge of caring for cancer patients. A diagnosis of cancer can be overwhelming for a patient and their family. From the beginning he will review the diagnosis in detail, the treatment options, and the potential results of each option, including possible side effects. Dr. Landis enjoys seeing his patients over time, during the course of treatment, and in follow-up. Often it takes some time to understand the patients priorities and wishes. As a physician, he believes in prioritizing the patients quality of life and listening to understand their desires and incorporate this into an individualized treatment plan. He strives to provide the best possible care to all of his patients. Dr. Landis is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Nasopharyngeal Carcinoma, Familial Prostate Cancer, Prostate Cancer, and Primitive Neuroectodermal Tumor (PNET). Dr. Landis is board certified in American Board Of Radiology. Dr. Landis is currently accepting new patients.

Matthew Howenstein is an Interventional Radiologist practicing medicine in Grafton, Wisconsin. Dr. Howenstein is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Visceromegaly, Thyroid Nodule, Lung Nodules, Bone Marrow Aspiration, and Vertebroplasty. Dr. Howenstein is board certified in American Board Of Radiology, Interventional Radiology And Diagnostic Radiology.

Edward James is a Hematologist and an Oncologist practicing medicine in Park Ridge, Illinois. Dr. James is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Gastrostomy. Dr. James is board certified in American Board Of Internal Medicine, Medical Oncology.

Dr. Gold is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. Gold is Director of Clinical Research and the Program Leader for the Gastrointestinal (GI) Oncology Program at the Swedish Cancer Institute in Seattle, Washington. In 1991, Dr. Gold obtained his degree in medicine with a distinction in research at the University of Miami School of Medicine in Florida. He then completed an internal medicine internship and residency at the University of Washington. Dr. Gold received the Amgen Oncology Fellowship Award while he was training in medical oncology at the University of Washington School of Medicine and the Fred Hutchinson Cancer Research Center. Presently, he is board certified in medical oncology. Dr. Gold’s clinical investigations on GI tumors, and particularly colorectal cancer treatment, can be found in peer-reviewed publications like the Journal of Clinical Oncology, Seminars in Oncology, and Cancer Investigation. Furthermore, he currently serves as a member of the NCI Colon Task Force, and the Southwest Oncology Group, where he serves as the subcommittee co-chair for colon cancer. In his free time, Dr. Gold enjoys photography and spending time with his wife and three sons. Dr. Gold is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Neuroendocrine Tumor, and Lynch Syndrome. Dr. Gold is board certified in American Board Of Internal Medicine. Dr. Gold is currently accepting new patients.

Dr. Sui earned a medical degree from Qingdao University, China, and a Ph.D. from the University of Tokyo, Japan. He conducted postdoctoral research in hematology at Vanderbilt University, an internal medicine residency at the University of Tennessee, and a medical oncology fellowship at the Fred Hutchinson Cancer Research Center and the University of Washington. He is board certified in internal medicine and medical oncology. He was an associate professor at Shangdong. Dr. Sui believes in treating his patients as if they were his own family members. Dr. Sui is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 51 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Lung Cancer, Pleuropulmonary Blastoma, and Large-Cell Immunoblastic Lymphoma. Dr. Sui is board certified in American Board Of Internal Medicine. Dr. Sui is currently accepting new patients.

Dr. Mehta is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. He enjoys working with patients and family members. There are a wide variety of treatment options available for nearly every patient, so it is important to spend as much time as is needed in order to weight the benefits and risks to any particular approach. He feels that it is important that communication is open and honest. The goals of treatment, whether it is going for cure or maximizing quality of life should be openly discussed and re-discussed as the need arises. Dr. Mehta is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer). Dr. Mehta is board certified in American Board Of Radiology. Dr. Mehta is currently accepting new patients.

Christopher Stark is an Interventional Radiologist practicing medicine in Cooperstown, New York. Dr. Stark is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Ascites, Lymphofollicular Hyperplasia, Peripheral Artery Disease, Bone Marrow Aspiration, and Liver Embolization. Dr. Stark is board certified in American Board Of Radiology.

Ahmed Kaseb is an Oncologist practicing medicine in Houston, Texas. Dr. Kaseb is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Liver Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Hepatectomy, and Liver Embolization.

Ghassan Abou is an Oncologist practicing medicine in New York, New York. Dr. Abou is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Fibrolamellar Carcinoma, Liver Embolization, and Pancreaticoduodenectomy. Dr. Abou is currently accepting new patients.

Raymond Yeung is a General Surgeon practicing medicine in Seattle, Washington. He has been practicing medicine for over 44 years. Dr. Yeung is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Adenocarcinoma, and Hepatectomy.

Gadi Lalazar is a Gastroenterologist practicing medicine in New York, New York. Dr. Lalazar is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), and Liver Cancer.

Erik Schadde is a General Surgeon practicing medicine in Madison, Wisconsin. Dr. Schadde is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Liver Cancer, Enlarged Liver, Hepatectomy, and Hepato-Pancreato-Biliary Surgery.

Jordan Tasse is an Interventional Radiologist practicing medicine in Chicago, Illinois. Dr. Tasse is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Varicose Veins, Familial Pancreatic Cancer, Liver Embolization, and Angioplasty.